Clonal Analysis

For certain gene therapy clinical trials, the FDA has required post-trial monitoring of patients, evaluating clinical samples for evidence of clonal expansion of cells (PDF). To help investigators comply with this FDA recommendation, the NGVB offers assistance with clonal analysis using nrLAM PCR technology at a subsidized rate. If you are interested in this service:

Request Testing Services

If you have any questions feel free to contact the NGVB Biorepository Manager:

Lorraine Matheson
Please enable JavaScript in your browser to see the e-mail address.